In L6 skeletal muscle cells and immortalized hepatocytes, insulin induced a 2-fold increase in the activity of the pyruvate dehydrogenase (PDH) complex. This effect was almost completely blocked by the protein kinase C (PKC) ␦ inhibitor Rottlerin and by PKC␦ antisense oligonucleotides. At variance, overexpression of wild-type PKC␦ or of an active PKC␦ mutant induced PDH complex activity in both L6 and liver cells. Insulin stimulation of the activity of the PDH complex was accompanied by a 2.5-fold increase in PDH phosphatases 1 and 2 (PDP1/2) activity with no change in the activity of PDH kinase. PKC␦ antisense blocked insulin activation of PDP1/2, the same as with PDH. In insulin-exposed cells, PDP1/2 activation was paralleled by activation and mitochondrial translocation of PKC␦, as revealed by cell subfractionation and confocal microscopy studies. The mitochondrial translocation of PKC␦, like its activation, was prevented by Rottlerin. In extracts from insulinstimulated cells, PKC␦ co-precipitated with PDP1/2. PKC␦ also bound to PDP1/2 in overlay blots, suggesting that direct PKC␦-PDP interaction may occur in vivo as well. In intact cells, insulin exposure determined PDP1/2 phosphorylation, which was specifically prevented by PKC␦ antisense. PKC␦ also phosphorylated PDP in vitro, followed by PDP1/2 activation. Thus, in muscle and liver cells, insulin causes activation and mitochondrial translocation of PKC␦, accompanied by PDP phosphorylation and activation. These events are necessary for insulin activation of the PDH complex in these cells.